Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-08-06
2008-10-14
Prouty, Rebecca E. (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C530S350000, C530S300000, C540S200000, C548S303700
Reexamination Certificate
active
07435727
ABSTRACT:
The invention describes a method for isolating an intestinal protein which is able to bind cholesterol and/or cholesterol uptake inhibitors. Methods of identifying inhibitors of cholesterol uptake and related pharmaceuticals and methods of treatment also are described.
REFERENCES:
patent: 2002/0009714 (2002-01-01), Altmann et al.
patent: WO 00/63703 (2000-10-01), None
patent: WO 02/18432 (2002-03-01), None
patent: WO 0218432 (2002-03-01), None
Kramer et al., “Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter,” FEBS Letters 487:293-297, 2000.
Werner Kramer et al., “Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter”, FEBS Letters 487, 2000, pp. 293-297.
Frick Wendelin
Kramer Werner
Kosson Rosanne
Prouty Rebecca E.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Method for isolating an intestinal cholesterol binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for isolating an intestinal cholesterol binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for isolating an intestinal cholesterol binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4013001